SOURCE: Blood Diagnostics, Inc.

April 25, 2008 09:00 ET

Blood Diagnostics, Inc. (BDI) Announces First Quarter Growth

COLUMBIA, SC--(Marketwire - April 25, 2008) - Blood Diagnostics, Inc. (BDI), a national leader in the distribution of biopharmaceutical products, announced that sales for the first quarter of 2008 represented a twenty-seven percent (27%) increase in comparison to Q1 2007. This pace is ahead of the company's average rate of growth for the preceding three fiscal calendar years. BDI's revenues have grown at an average rate of twenty-three percent (23%) per year from 2004 - 2007.

"We are pleased to see sales tracking forward of historical growth," said Richard J. Gaton, co-president of BDI. "Our growth remains attributable to no single factor; rather, it is a reflection of the depth of our trade relations, the quality of our personnel, the impact of our marketing, and the successful culmination of proprietary program and contract initiatives."

About BDI

Blood Diagnostics, Inc. (BDI) is a national specialty distributor of biopharmaceutical products. For more than a decade, the company has built an excellent reputation as an industry source for products and service. Serving the healthcare community since 1995, BDI has been committed to specialty biotherapeutics, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it distributes, BDI is fully accredited and insured. BDI fulfills the licensing requirements in all 50 states. With distribution centers located on both coasts, BDI offers prompt shipping as well as emergency delivery service.

Emergency 24 / 7 availability, unparalleled customer service, and extensive product knowledge define BDI's customer-centric approach to serving the nation's healthcare community. The company serves as a free source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI's promotional literature and web site -- www.ivig.com -- serve as open-access educational resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.

Contact Information

  • Media Contact:
    Brad Davis
    Director of Marketing
    1-800-948-9834
    Email Contact